Study on Bisphosphonates Targeting Triple-negative Breast Cancer

NCT04045522 · clinicaltrials.gov ↗

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Zoledronic Acid

Sponsor

Shengjing Hospital

Collaborators

[object Object]
[object Object]